Categories: DevelopmentDrugGamingHumanProductionResearch
NewAmsterdam Pharma acquired Dezima Pharma and is now a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
Investors 2
Funding Rounds 2
Date | Series | Amount | Investors |
02.07.2020 | - | $20.79M | - |
03.07.2019 | Series A | $16.93M | - |
Mentions in press and media 4
Date | Title | Description | Source |
02.07.2020 | Citryll completes € 18.5 M fundraise to develop CIT-013, an ... | OSS, Netherlands-Citryll announced it closed a total fundraise of € 18.5 million, led by Seventure (... | seventure.... |
02.07.2020 | Citryll Closes €18.5M Funding Round | Citryll, an Oss, Netherlands-based pharmaceutical company, closed a total funding of €18.5m.
The ro... | finsmes.co... |
03.07.2019 | Citryll Holds First Closing of €15M Series A Funding | Citryll, an Oss, Netherlands-based pharmaceutical company, held the first closing of a targeted €15m... | finsmes.co... |
03.07.2019 | Dutch medtech startup Citryll completes first closing of €15... | When it comes to healthcare and MedTech, Europe is the place bursting with innovations and other sol... | siliconcan... |
Reviews 0